Pancreatic Cancer Research

ResearcherOregon Health & Science UniversityNo recent work listed

Gina M. Vaccaro

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3934-0806; OpenAlex author ID A5036400761. Sources: ClinicalTrials.gov.

Their work

Papers
4 (first author 0, last author 1)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
22
Papers, trials and grants by year

2016: 1 trial · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 2 papers

Papers 4

  1. Phase 2 study of preoperative chemotherapy with nab-paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node-positive pancreatic… Last author DOI 10.1002/cam4.5971↗
  2. Modulation of myeloid and T cells in vivo by Bruton's tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/jitc-2022-005425↗
  3. A Phase 3 Randomized Clinical Trial of Chemotherapy With or Without Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy in Subjects With Borderline Resectable … Co-author DOI 10.1097/sla.0000000000004669↗
  4. Chemoradiation for Locally Advanced Unresectable Pancreatic Cancer-What Now? Co-author DOI 10.1001/jamaoncol.2016.3012↗

Trials 1

  1. Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Su… Principal investigator NCT02427841↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Charles D. Lopez · 3 shared papers, 2017–2023 · strength 0.42
  2. Brett C. Sheppard · 1 shared paper, 2023 · strength 0.15
  3. Aaron J. Grossberg · 1 shared paper, 2023 · strength 0.15
  4. Skye C. Mayo · 1 shared paper, 2023 · strength 0.15
  5. Adel Kardosh · 1 shared paper, 2023 · strength 0.15
  6. Emerson Yu-sheng Chen · 1 shared paper, 2023 · strength 0.15
  7. Charles R. Thomas · 1 shared paper, 2023 · strength 0.15
  8. Lisa M. Coussens · 1 shared paper, 2023 · strength 0.13
  9. Meenal Sinha · 1 shared paper, 2023 · strength 0.13
  10. Lawrence H. Fong · 1 shared paper, 2023 · strength 0.13
  11. Margaret A. Tempero · 1 shared paper, 2023 · strength 0.13
  12. Li Zhang · 1 shared paper, 2023 · strength 0.13
  13. Hassan A. Hatoum · 1 shared paper, 2022 · strength 0.12
  14. Noelle K. LoConte · 1 shared paper, 2022 · strength 0.12
  15. Nicholas N. Nissen · 1 shared paper, 2022 · strength 0.12
  16. Gabriela R. Rossi · 1 shared paper, 2022 · strength 0.12
  17. Andrew L. Coveler · 1 shared paper, 2022 · strength 0.12
  18. Daniel Brock Hewitt · 1 shared paper, 2022 · strength 0.12
  19. Thomas J. George · 1 shared paper, 2022 · strength 0.12
  20. Harish Lavu · 1 shared paper, 2022 · strength 0.12
  21. Benjamin Musher · 1 shared paper, 2022 · strength 0.12
  22. Charles J. Yeo · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.